BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7683605)

  • 1. Neurophysiological evaluation in myasthenia gravis. A comprehensive study of a complete patient population.
    Somnier FE; Trojaborg W
    Electroencephalogr Clin Neurophysiol; 1993 Apr; 89(2):73-87. PubMed ID: 7683605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic sensitivity of the laboratory tests in myasthenia gravis.
    Oh SJ; Kim DE; Kuruoglu R; Bradley RJ; Dwyer D
    Muscle Nerve; 1992 Jun; 15(6):720-4. PubMed ID: 1324429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myasthenia gravis.
    Somnier FE
    Dan Med Bull; 1996 Feb; 43(1):1-10. PubMed ID: 8906977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evoked responses in normal and diseased muscle with particular reference to twitch potentiation.
    Krarup C
    Acta Neurol Scand; 1983 Nov; 68(5):269-315. PubMed ID: 6320576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acetylcholine receptor antibody titer, sensitivity to curare electromyogram and disease severity in myasthenia gravis].
    Chen SM
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Jun; 24(3):169-73, 189. PubMed ID: 1889330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seronegative myasthenia gravis: comparison of neurophysiological picture in MuSK+ and MuSK- patients.
    Padua L; Tonali P; Aprile I; Caliandro P; Bartoccioni E; Evoli A
    Eur J Neurol; 2006 Mar; 13(3):273-6. PubMed ID: 16618345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antibodies in myasthenia gravis].
    Eymard B
    Rev Neurol (Paris); 2009 Feb; 165(2):137-43. PubMed ID: 19162288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical correlation of anti-receptor antibody titer, sensitivity to curare and electromyographic changes in experimental autoimmune myasthenia gravis].
    Chen SM
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1990 Oct; 23(5):293-6, 320. PubMed ID: 2282884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies.
    Lindstrom JM; Engel AG; Seybold ME; Lennon VA; Lambert EH
    J Exp Med; 1976 Sep; 144(3):739-53. PubMed ID: 182897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical and electrophysiological peculiarities of seronegative myasthenia].
    Shcherbakova NI; Sanadze AG; Sidnev DV; Rudnichenko VA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(3):4-10. PubMed ID: 18427534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiologic diagnosis of myasthenia gravis and the regional curare test.
    Horowitz SH; Genkins G; Kornfeld P; Papatestas AE
    Neurology; 1976 May; 26(5):410-7. PubMed ID: 177903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between anti-acetylcholine receptor antibody titres and severity of myasthenia gravis.
    Aurangzeb S; Tariq M; Irshad M; Badshah M; Khan RS
    J Pak Med Assoc; 2009 May; 59(5):289-92. PubMed ID: 19438131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repetitive nerve stimulation vs. twitch tension in rats with EAMG.
    Thompson PA; Barohn RA; Krolick KA
    Muscle Nerve; 1992 Jan; 15(1):94-100. PubMed ID: 1732768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repetitive nerve stimulation of facial muscles in MuSK antibody-positive myasthenia gravis.
    Oh SJ; Hatanaka Y; Hemmi S; Young AM; Scheufele ML; Nations SP; Lu L; Claussen GC; Wolfe GI
    Muscle Nerve; 2006 Apr; 33(4):500-4. PubMed ID: 16392120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophysiological findings in patients with low density lipoprotein receptor related protein 4 positive myasthenia gravis.
    Nikolic AV; Bojic SD; Rakocevic Stojanovic VM; Basta IZ; Lavrnic DV
    Eur J Neurol; 2016 Nov; 23(11):1635-1641. PubMed ID: 27415961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Myasthenia gravis with electrophysiological features of Lambert-Eaton myasthenic syndrome: usefulness of serum autoantibodies assay and neuromuscular junction biopsy].
    Matsumoto R; Motomura M; Yoshimura T; Kohara N; Kato T
    Rinsho Shinkeigaku; 1999 May; 39(5):531-7. PubMed ID: 10424144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors affecting outcome in ocular myasthenia gravis.
    Mazzoli M; Ariatti A; Valzania F; Kaleci S; Tondelli M; Nichelli PF; Galassi G
    Int J Neurosci; 2018 Jan; 128(1):15-24. PubMed ID: 28625092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posttetanic potentiation in a patient with myasthenia gravis.
    Singer P; Smith L; Ziegler DK; Festoff BW
    Neurology; 1981 Oct; 31(10):1345-7. PubMed ID: 6287354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myasthenia gravis: pathophysiology, diagnosis and collaborative care.
    Kernich CA; Kaminski HJ
    J Neurosci Nurs; 1995 Aug; 27(4):207-15; quiz 216-8. PubMed ID: 7499922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurophysiological and mitochondrial abnormalities in MuSK antibody seropositive myasthenia gravis compared to other immunological subtypes.
    Rostedt Punga A; Ahlqvist K; Bartoccioni E; Scuderi F; Marino M; Suomalainen A; Kalimo H; Stålberg EV
    Clin Neurophysiol; 2006 Jul; 117(7):1434-43. PubMed ID: 16737845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.